Technical Support: menoci@medizin.uni-goettingen.de
Department of Medical Informatics
University Medical Center Göttingen
Imprint
PID | primary-0349 |
EPIC PID | https://hdl.handle.net/21.11124/primary-0349 |
Research group | RG Preobraschenski |
Quality (mean) | no score (0.00) |
Sharing level | Public |
Antigen symbol | IGF2 |
Antibody Registry ID(s) | AB_308725 |
Name | Anti-IGF2 antibody |
Alternative name | C11orf43 antibody |
Lab ID | |
Tag / Fluorophore | |
Raised in | Rabbit |
Reacts with | RecombinantFragment |
Clone | |
Isotype | IgG |
Clonality | polyclonal |
Demasking | unknown |
Antigen | Highly pure (>98%) recombinant hIGF-2 (human Insulin Like Growth Factor-2) |
Crafted By | company |
Company / Manufacturer | Abcam |
Catalog no. | ab9574 |
Lot no. | |
Description | WB (6) Use at an assay dependent concentration. To detect hIGF-2 by Western Blot analysis this antibody can be used at a concentration of 0.1 - 0.2 µg/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant hIGF-2 is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions. Sandwich ELISA Use at an assay dependent concentration. To detect hIGF-II by sandwich ELISA (using 100 μl/well antibody solution) a concentration of 0.5 - 2.0 μg/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with ab83142, allows the detection of at least 0.2 - 0.4 ng/well of |
Localization | Secreted. |
Storage instruction | Shipped at 4°C. Store at -20ºC. |
Receipt date | 2021-04-17 00:00:00 |
Preparation date | 2021-04-17 00:00:00 |
Created by | Klauenberg, Vanessa |
Last modified | Klauenberg, Vanessa |
Antibodypedia | - |
HGNC | http://www.genenames.org/cgi-bin/gene_symbol_report?match=IGF2 |
Wikipedia | http://en.wikipedia.org/wiki/IGF2 |
Uniprot | http://www.uniprot.org/uniprot/?query=IGF2 |
GeneCards | http://www.genecards.org/cgi-bin/carddisp.pl?gene=IGF2 |
Antibody Registry | http://antibodyregistry.org/search?q=AB_308725 |
No application comments yet.
Distinct insulin granule subpopulations implicated in the secretory pathology of diabetes types 1 and 2
Kreutzberger AJ, Kiessling V, Doyle CA, Schenk N, Upchurch CM, Elmer-Dixon M, Ward AE, Preobraschenski J, Hussein SS, Tomaka W, Seelheim P, Kattan I, Harris M, Liang B, Kenworthy AK, Desai BN, Leitinger N, Anatharam A, Castle JD, Tamm LK
eLife 2020 : 10.7554/elife.62506